Posit Presentations at Phuse US
Workshop
Sunday, March 16
2:30-4:00 PM in Oceans 10 – Next Generation Clinical Workflows in R with Posit Team
Instructors: Phil Bowsher, Michael Mayer, Aaron Jacobs
Learn more here.
Speaking Sessions
Wednesday, March 199-9:30 AM in Oceans 9 –
Positron: Overview for PharmaPresenter: Philip Bowsher
Positron is a next generation data science IDE. As an extensible tool, it is built to facilitate exploratory data analysis, reproducible authoring, and statistical programming. More and more Pharmaceutical organizations are using Python for late-stage clinical reporting. Positron currently supports workflows in either or both Python and/or R, and is designed with a forward-looking architecture that can support other data science languages in the future. Posit/RStudio will be presenting an update regarding Positron.This talk will discuss opportunities and applications for the new IDE and how it can empower stakeholders and statistical programmers. This talk will explore and discuss areas such as TLGs creation with python and provide examples for getting started.
12-12:30 PM in Oceans 10 – Posit Team: Metadata-Driven Risk Assessment and Surfacing Validated R Packages
Presenter: Michael Mayer
Pharmaceutical organizations often have Standard Operating Procedures (SOP) to “Validate” Packages. Many organizations then freeze open source packages in Posit Package Manager and distribute via an internal repository for clinical trials. Statistical Programming and Clinical Quality Assurance (QA) teams regularly follow a risk-based approach (R Validation Hub) for “package inclusion” in open source validated GxP environments. Posit/RStudio will be presenting an update regarding support for these activities in sharing packages in Statistical Computing Environments. This talk will discuss opportunities and applications for sharing validated packages and information to empower stakeholders, IT administrators and statistical programmers. Attendees will learn about areas such as metadata and Posit Team and where they are being used, terminology, current research, etc. to inform both users and administrators when or why packages are available (or for an assessment) for use in regulatory submissions.